AngioDynamics | ANGO - Operating Expenses

Stock Price
10.86
Daily Change
0.40 3.82%
Monthly
4.42%
Yearly
17.41%
Q2 Forecast
10.62

AngioDynamics reported $81.95M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Inogen USD 49.14M 665K Sep/2024
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Smiths GBP 749M 617M Jun/2026
Surmodics USD 29.51M 274.86M Jun/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025